Calendar
event
Ex dividend date
01 Jul 2026
calendar_clock
Next Dividend Payment
15 Jul 2026
About Encompass Health Corp
Ticker
info
EHC
Trading on
info
NYSE
ISIN
info
US29261A1007
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Mark J. Tarr
Headquarters
info
9001 Liberty Parkway, Birmingham, AL, United States, 35242
Employees
info
29,599
Website
info
encompasshealth.com
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Metrics
BasicAdvanced
Market cap
info
$9.86B
P/E ratio
info
17.37
EPS
info
$5.72
Dividend Yield
info
0.73%
Beta
info
0.6
Forward P/E ratio
info
17.06
EBIDTA
info
$1.42B
Ex dividend date
info
2026-07-01
Price & volume
Market cap
info
$9.86B
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.74
Dividend yield
info
0.73%
Forward dividend per share
info
$0.76
Forward dividend yield
info
0.76%
Payout ratio
info
13.36%
Valuation
P/E ratio
info
17.37
Forward P/E
info
17.06
PEG ratio
info
0.41
Trailing P/E
info
17.37
Price to sales
info
1.62
Price to book
info
3.99
Earnings
EPS
info
$5.72
EPS estimate (current quarter)
info
$1.49
EPS estimate (next quarter)
info
$1.48
EBITDA
info
$1.42B
Revenues (TTM)
info
$6.07B
Revenues per share (TTM)
info
$60.56
Technicals
Beta
info
0.6
52-week High
info
$127.51
52-week Low
info
$92.59
50-day moving average
info
$104.53
200-day moving average
info
$109.86
Short ratio
info
3.46
Short %
info
3.82%
Management effectiveness
ROE (TTM)
info
25.23%
ROA (TTM)
info
9.74%
Profit margin
info
10.04%
Gross profit margin
info
$2.64B
Operating margin
info
19.01%
Growth
Quarterly earnings growth (YoY)
info
30.30%
Quarterly revenue growth (YoY)
info
9.00%
Share stats
Outstanding Shares
info
99.2M
Float
info
97.9M
Insiders %
info
1.07%
Institutions %
info
101.65%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 12 analysts.

Average price target

info
$140.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.40
$1.21
15.70%
Q2 • 25Beat
$1.23
$1.19
3.36%
Q3 • 25Beat
$1.46
$1.30
12.31%
Q4 • 25Beat
$1.60
$1.49
7.38%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.54B
$146M
9.46%
Q4 • 25
$1.59B
$195M
12.26%
Q1 • 26
2.72%
33.13%
29.60%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$7.09B
$3.81B
53.79%
Q4 • 25
$7.31B
$3.95B
53.96%
Q1 • 26
3.15%
3.46%
0.30%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$346M
-
$-99.2M
$117M
Q4 • 25
$313M
-
$-103M
$151M
Q1 • 26
-9.51%
-
3.33%
29.13%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Encompass Health Corp share?
Collapse

Encompass Health Corp shares are currently traded for undefined per share.

How many shares does Encompass Health Corp have?
Collapse

Encompass Health Corp currently has 99.2M shares.

Does Encompass Health Corp pay dividends?
Collapse

Yes, Encompass Health Corp does pay dividends.

What is Encompass Health Corp 52 week high?
Collapse

Encompass Health Corp 52 week high is $127.51.

What is Encompass Health Corp 52 week low?
Collapse

Encompass Health Corp 52 week low is $92.59.

What is the 200-day moving average of Encompass Health Corp?
Collapse

Encompass Health Corp 200-day moving average is $109.86.

Who is Encompass Health Corp CEO?
Collapse

The CEO of Encompass Health Corp is Mark J. Tarr.

How many employees Encompass Health Corp has?
Collapse

Encompass Health Corp has 29,599 employees.

What is the market cap of Encompass Health Corp?
Collapse

The market cap of Encompass Health Corp is $9.86B.

What is the P/E of Encompass Health Corp?
Collapse

The current P/E of Encompass Health Corp is 17.37.

What is the EPS of Encompass Health Corp?
Collapse

The EPS of Encompass Health Corp is $5.72.

What is the PEG Ratio of Encompass Health Corp?
Collapse

The PEG Ratio of Encompass Health Corp is 0.41.

What do analysts say about Encompass Health Corp?
Collapse

According to the analysts Encompass Health Corp is considered a buy.